Aminolevulinic Acid clinical trials
Also written 5-ALA, Levulan and Gleolan.
Includes 16 studies of Oral Aminolevulinic Acid Hydrochloride, 8 studies of BF-200 ALA and 1 study of Aminolevulinic acid phosphate.
How each study uses Aminolevulinic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Aminolevulinic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 Dec 1999 · LEVULAN · NDA 020965 (FDA, Drugs@FDA)
- European Union
- 7 Sept 2007 · Gliolan · EMEA/H/C/000744 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
113 studies that test it; most in 2014 (10); 1 more planned to start later
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1997 | 1 |
| 1999 | 2 |
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 30 · Other 84
DUSA Pharmaceuticals, Inc. (10) · Biofrontera Bioscience GmbH (5) · Joint Authority for Päijät-Häme Social and Health Care (4) · Roswell Park Cancer Institute (4) · Universität Münster (3) · The Center for Clinical and Cosmetic Research (3) · University of California, Davis (3) · photonamic GmbH & Co. KG (3)
Often tested with
Tested in the same studies.
Methyl aminolevulinate (5) · Photodynamic Therapy (2) · Hexaminolevulinate hydrochloride (1) · HhAntag691 (1) · Carmustine, poliferprosan 20 drug combination (1) · Iron (1) · Phototherapy (1) · Methyl aminolevulinate hydrochloride (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5
Studies that test Aminolevulinic Acid.
- Nov 2026Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.Phase 2 · The Center for Clinical and Cosmetic Research
- Dec 2026Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell CarcinomasPhase 1 · Nathalie Zeitouni
- Sep 2027Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic TherapyPhase 2 · Case Comprehensive Cancer Center
- Oct 2027TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly GliomaPhase 1 · Alpheus Medical, Inc.
- Nov 20275-AminoLevulinic Acid Aided Resection Margins in SarcomaEarly Phase 1 · University of Colorado, Denver
Studies
Open first, then newest update. How each study uses Aminolevulinic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 114
- Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.RecruitingPhase 2The Center for Clinical and Cosmetic ResearchNCT07931664Written as Aminolevulinic Acid 20% Topical Solution with Blue Light (dose 20 J/cm2)
- 5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant GliomaRecruitingPhase 3Lee's Pharmaceutical LimitedNCT06160492Written as 5-Aminolevulinic Acid Hydrochloride Powder for Oral Solution
- TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly GliomaRecruitingPhase 1Alpheus Medical, Inc.NCT07862647Written as 5-ALA
- A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor PatientsNot yet recruitingPhase 2Costas HadjipanayisNCT06907485Written as Aminolevulinic acid hydrochloride
- Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALARecruitingPhase 2Henry Ford Health SystemNCT06948552Written as 5-Aminolevulinic acid Hydrochloride (Gliolan®)
- Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALARecruitingPhase 2Henry Ford Health SystemNCT07828704Written as 5-Aminolevulinic acid Hydrochloride (Gliolan®)
- 5-AminoLevulinic Acid Aided Resection Margins in SarcomaNot yet recruitingEarly Phase 1University of Colorado, DenverNCT07038278Written as 5-ALA
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)RecruitingPhase 3NX Development CorpNCT05804370Written as Gleolan
- Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain TumorRecruitingPhase 1/2Universität MünsterNCT05590689Written as Gliolan
- Fluorescence Guided Focal Cortical Dysplasia SurgeryNot yet recruitingPhase 2Hospices Civils de LyonNCT07657975Written as 5-ALA (Gliolan)
- Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral LesionsNot yet recruitingPhase 2University of Massachusetts, BostonNCT06876038Written as 5-Amino Levulinic Acid
- Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell CarcinomasRecruitingPhase 1Nathalie ZeitouniNCT06623201Written as aminolevulinic acid HCL (ALA)
- The Use of 5-ALA in Paediatric Patients With High Grade Brain TumoursNot yet recruitingPhase 2University College, LondonNCT06678867Written as 5-ALA (Gliolan)
- Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)RecruitingPhase 2The Center for Clinical and Cosmetic ResearchNCT06577311Written as Aminolevulinic acid hydrochloride 10% topical gel with Red Light
- Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and PreventionRecruitingPhase 4Shanghai Dermatology HospitalNCT03642535Written as ALA
- Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids TumorsRecruitingPhase 2michal rollNCT01898416Written as 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
- Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full FaceActive, not recruitingPhase 4Psoriasis Treatment Center of Central New JerseyNCT06745999Written as Ameluz 10% Topical Gel
- PDT Plus Vitamin D3 for Anal DysplasiaWithdrawnPhase 1Abramson Cancer Center at Penn MedicineNCT02698293Written as Gliolan
- ALA-induced PpIX Fluorescence During Brain Tumor ResectionActive, not recruitingPhase 1David W. RobertsNCT02191488Written as 5-aminolevulinic acid
- Impact of PDT and Topical Corticosteroids on Taste Perception and Salivary Oxidative Stress Markers in Patients With OLPCompletedNot applicableMedical University of BialystokNCT07536737Written as 5-Amino Levulinic Acid
See all 114 studies that test Aminolevulinic Acid →
Given beside what is tested · 5 — Aminolevulinic Acid is usual care or a partner of the new treatment
- Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal CancerRecruitingPhase 1/2Roswell Park Cancer InstituteNCT06307548Written as Aminolevulinic Acid
- Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent GlioblastomaRecruitingEarly Phase 1Mayo ClinicNCT07076472Written as Oral Aminolevulinic Acid Hydrochloride
- Photodynamic Therapy in Treating Patients With Refractory Mycosis FungoidesCompletedEarly Phase 1Mayo ClinicNCT03281811Written as Aminolevulinic Acid Hydrochloride
- The Use of Microneedles in Photodynamic TherapyCompletedNot applicableUniversity of California, DavisNCT01812837Written as Aminolevulinic Acid
- Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation ProtocolCompletedNot applicableVastra Gotaland RegionNCT02644187Written as BF200-ALA/5-aminolevulinic acid
As the comparator · 1 — what is tested is compared with Aminolevulinic Acid
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call Aminolevulinic Acid · ClinicalTrials.gg INT006952
- MeSH (NLM) D000622Aminolevulinic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 88755TAZ87AMINOLEVULINIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 683Confirmed FDA, Wikidata
- Wikidata Q238474aminolevulinic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C234Aminolevulinic AcidOne source FDA
- DrugBank DB00855One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000622 | Aminolevulinic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 88755TAZ87 | AMINOLEVULINIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 683 | — | Confirmed FDA, Wikidata |
| Wikidata | Q238474 | aminolevulinic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C234 | Aminolevulinic Acid | One source FDA |
| DrugBank | DB00855 | — | One source Wikidata |
Also registered as aminolevulinic acid hydrochloride (UNII V35KBM8JGR · RxNorm 261715).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.